The Readout Loud

View Top 200 Chart

Back to Rankings Page

Business
**The Readout Loud**

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Latest Episodes:

Episode 98: Les Funtleyder on biotech investing; the Zolgensma lottery & billionaire philanthropy Feb 13, 2020

Show notes

What's the right way to give drugs away? Is $3 billion even a lot of money? And when is biotech hype justified?

Episode 97: Fake outbreak news, treating coronavirus, and biotech's Mount Rushmore Feb 06, 2020

Show notes

Is peer review underrated? Can biotech stop an outbreak? And would you mind giving us a call? We're coming up on the 100th episode of this podcast, and we're using the occasion to actualize our long-held dream of running a call-in show. Dial us at 617-517-6130 and leave a message with any question you'd like us to answer on the podcast, and you may just hear it on air in the coming weeks.

Episode 96: A chemist breaks bad, the latest on the coronavirus, and pharma’s slow Bern Jan 30, 2020

Show notes

Is it wise to lie to the feds? Is pharma taking Sen. Bernie Sanders seriously? And what constitutes a "public health emergency of international concern?"

Episode 95: The latest on the China virus, Sarepta's ongoing FDA saga, and biotech at Davos Jan 23, 2020

Show notes

Are we dealing with a SARS redux? Has the FDA lost its teeth? And what do billionaires talk to each other about?

Episode 94: EQRx's Alexis Borisy, Stephen Buck on his website for cancer patients, and a JPM recap Jan 16, 2020

Show notes

Why weren't there any big deals announced this week? What does the word "equivalar" mean? And why is information about prognosis so hard to find?

Episode 93: Josiah Zayner on getting canceled, good news in cancer, an Ebola vaccine saga Jan 09, 2020

Show notes

Does pharma deserve more credit? Will history forgive He Jiankui? And how does a laboratory eureka become a lifesaving vaccine?

Episode 92: The decade in breakthroughs, the year in bad CEOs, and the viruses that cure disease Dec 19, 2019

Show notes

Which drug defined the decade? Who's the worst CEO in biopharma? And how does gene therapy actually work?

Episode 91: CAR-T's future, an alarming cancer trend & Chris Garabedian on Sarepta's FDA legacy Dec 12, 2019

Show notes

Has CAR-T lost its luster? Why is colorectal cancer on the rise? And did the FDA forever change in 2016?

Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep Dec 05, 2019

Show notes

How do you know if a "positive" study is positive? And how did one-eyed sheep lead to a drug for certain cancers?

Episode 89: Warren's awkward home front, a dwarfism drug, and the sound of STAT Summit Nov 22, 2019

Show notes

Can Sen. Elizabeth Warren ever go home again? Is it ethical to make little people taller? And when will AI come up with a new drug?

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected